Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ARK Genomic Revolution ETF (ARKG) vs Avantis International Small Cap Value ETF (AVDV) Price & Performance

ARK Genomic Revolution ETFTrade
Avantis International Small Cap Value ETFTrade

Price performance (Past 24H)

Key statistics

ARK Genomic Revolution ETF vs Avantis International Small Cap Value ETF — how do they compare? ARK Genomic Revolution ETF trades at $44.59, while Avantis International Small Cap Value ETF trades at $110.37. Which is the better fit depends on your goals.

ARKGAVDV
Sector
Sector/ThematicSector/Thematic
52-Week High
$44.55$110.40
52-Week Low
$24.02$83.89

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ARK Genomic Revolution ETF

No Aura AI signal available yet.

Avantis International Small Cap Value ETF

AVDV trades at $110.51, up 0.96% today, with a bullish technical outlook from moving averages but caution from oscillators like the 6-day RSI at 87.64 indicating overbought conditions. Recent news highlights strong 2026 performance, with international small-cap value strategies gaining attention. The stock shows support near $108-$109 and resistance at $110.

The outlook remains positive due to momentum in international small-cap value, though overbought signals and reliance on commodity sectors pose risks. Investors should weigh the ETF's diversification benefits against potential volatility from global economic shifts.

Returns comparison

Trailing returns across standard periods

About ARK Genomic Revolution ETF

ARKG is an actively managed ETF that invests in the genomic revolution. It focuses on companies leading in gene editing, CRISPR technology, therapeutics, and molecular diagnostics, including firms like CRISPR Therapeutics and Tempus AI.

Read more on ARKG

About Avantis International Small Cap Value ETF

AVDV is an actively managed ETF that targets small-cap value companies in developed markets outside the United States. It uses a systematic, rules-based process to identify firms trading at low valuations with high profitability, aiming to capture the 'size' and 'value' premiums while maintaining broad diversification.

Read more on AVDV